PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.90
+0.10 (0.23%)
Aug 3, 2026, 2:45 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.45 billion as of August 3, 2026. Its market cap has increased by 93.44% in one year.
Market Cap
1.45B
Enterprise Value
1.51B
Revenue
362.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.90
ChartMarket Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.45B, a decrease of -44.19%. That is a compound annual growth rate of -10.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.45B | 67.89% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 282.27B |
| Novartis AG | 240.63B |
| Galderma Group AG | 41.23B |
| Lonza Group AG | 39.27B |
| Tecan Group AG | 2.33B |
| Idorsia | 1.56B |
| SKAN Group AG | 1.32B |
| Aevis Victoria | 1.10B |